At two or more years after starting treatment, the odds of a new diagnosis of alopecia in GLP-1 users were 37% higher than in users of so-called SGLT-2 drugs and 68% higher versus DPP-4 drugs, researchers at the University of Pennsylvania reported Wednesday in The BMJ
Since starting my program at Marino Wellness, I've felt supported every step of the way
I would not recommend microdosing GLP-1s for individuals with significant amounts of weight to lose or known metabolic dysregulation. The bottom line is that there are still questions regarding the effectiveness and safety of microdosing GLP-1 medications, and this type of regimen is not for everyone
Review the denial letter Carefully examine the letter to understand the specific reason for denial and the appeal process
Fruits, vegetables, whole grains, legumes, and dairy products are some whole foods that naturally have carbohydrates in them